semaglutide and vision issues A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Specialists discuss concerns over impact
Description
Your Weight Loss Journey Starts Here Real results
El Dorado Hills, CA
After a median follow-up of 2.5 years, GLP-1 RAs users had lower risks of mortality (adjusted hazard ratio (aHR), 0.39
Investigative potential in: GLP-1 receptor interaction mapping and incretin-pathway characterization
GLP, a leading investor and developer of logistics warehouses and distribution parks, today announces its first acquisition in Belgium, of a recently developed 60,000 SQ M facility in Ghent
